RS57139B1 - Novi biciklični derivati dihidrohinolin-2-ona - Google Patents

Novi biciklični derivati dihidrohinolin-2-ona

Info

Publication number
RS57139B1
RS57139B1 RS20180446A RSP20180446A RS57139B1 RS 57139 B1 RS57139 B1 RS 57139B1 RS 20180446 A RS20180446 A RS 20180446A RS P20180446 A RSP20180446 A RS P20180446A RS 57139 B1 RS57139 B1 RS 57139B1
Authority
RS
Serbia
Prior art keywords
dihydroquinoline
derivatives
new bicyclic
bicyclic
new
Prior art date
Application number
RS20180446A
Other languages
English (en)
Inventor
Johannes Aebi
Kurt Amrein
Serena Maria Fantasia
Benoit Hornsperger
Bernd Kuhn
Yongfu Liu
Hans P Maerki
Alexander V Mayweg
Peter Mohr
Michelangelo Scalone
Xuefei Tan
Mingwei Zhou
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46963698&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RS57139(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of RS57139B1 publication Critical patent/RS57139B1/sr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/42Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
RS20180446A 2011-09-23 2012-09-20 Novi biciklični derivati dihidrohinolin-2-ona RS57139B1 (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN2011080078 2011-09-23
EP12766628.7A EP2758388B1 (en) 2011-09-23 2012-09-20 New bicyclic dihydroquinoline-2-one derivatives
PCT/EP2012/068472 WO2013041591A1 (en) 2011-09-23 2012-09-20 New bicyclic dihydroquinoline-2-one derivatives

Publications (1)

Publication Number Publication Date
RS57139B1 true RS57139B1 (sr) 2018-07-31

Family

ID=46963698

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20180446A RS57139B1 (sr) 2011-09-23 2012-09-20 Novi biciklični derivati dihidrohinolin-2-ona

Country Status (33)

Country Link
US (1) US9353081B2 (sr)
EP (1) EP2758388B1 (sr)
JP (1) JP6012737B2 (sr)
KR (1) KR101723276B1 (sr)
CN (1) CN103827101B (sr)
AR (1) AR087984A1 (sr)
AU (1) AU2012311582B2 (sr)
BR (1) BR112014006660B1 (sr)
CA (1) CA2845170C (sr)
CL (1) CL2014000663A1 (sr)
CO (1) CO6870035A2 (sr)
CR (1) CR20140089A (sr)
DK (1) DK2758388T3 (sr)
EA (1) EA035108B1 (sr)
EC (1) ECSP14013264A (sr)
ES (1) ES2666802T3 (sr)
HR (1) HRP20180592T1 (sr)
HU (1) HUE038773T2 (sr)
IL (1) IL230874A (sr)
LT (1) LT2758388T (sr)
MX (1) MX366095B (sr)
MY (1) MY186165A (sr)
NO (1) NO2758388T3 (sr)
PE (2) PE20181378A1 (sr)
PL (1) PL2758388T3 (sr)
PT (1) PT2758388T (sr)
RS (1) RS57139B1 (sr)
SG (1) SG2014010599A (sr)
SI (1) SI2758388T1 (sr)
TW (1) TWI576342B (sr)
UA (1) UA115972C2 (sr)
WO (1) WO2013041591A1 (sr)
ZA (1) ZA201401577B (sr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA117092C2 (uk) 2011-09-06 2018-06-25 Байєр Інтеллектуал Проперті Гмбх Амінозаміщені імідазопіридазини
CA2861060A1 (en) * 2012-04-17 2013-10-24 F. Hoffmann-La Roche Ag New phenyl-tetrahydroisoquinoline derivatives
ES2646916T3 (es) 2012-11-19 2017-12-18 Bayer Pharma Aktiengesellschaft Aminoimidazopiridazinas como inhibidores de MKNK1 cinasa
MX2015011005A (es) * 2013-03-14 2015-10-22 Hoffmann La Roche Derivados de dihidorquinolin-2-ona para usarse como inhibidores de aldoesterona sintasa.
LT3004076T (lt) * 2013-05-27 2020-01-10 F. Hoffmann-La Roche Ag Nauji 3,4-dihidro-2h-izochinolin-1-ono ir 2,3-dihidro-izoindol-1-ono junginiai
SI3004077T1 (sl) * 2013-05-27 2020-01-31 F. Hoffmann-La Roche Ag Novi spojini 3,4-dihidro-2H-izokinolin-1-on in 2,3-dihidro-izoindol-1-on
EP3004089B1 (en) * 2013-05-27 2020-05-06 F.Hoffmann-La Roche Ag New 3,4-dihydro-2h-isoquinoline-1-one and 2,3-dihydro-isoindol-1-one compounds
RU2016116435A (ru) * 2013-10-17 2017-11-22 Ф. Хоффманн-Ля Рош Аг Производные фенил-дигидропиридина в качестве ингибиторов альдостеронсинтазы
CN105593212B (zh) * 2013-10-17 2019-06-04 豪夫迈·罗氏有限公司 作为醛固酮合酶抑制剂的苯基-二氢吡啶衍生物
WO2015055604A1 (en) * 2013-10-17 2015-04-23 F. Hoffmann-La Roche Ag New phenyl-dihydropyridine derivatives as aldosterone synthase inhibitors
CN106604917B (zh) * 2014-10-31 2020-10-09 豪夫迈·罗氏有限公司 作为醛固酮合酶抑制剂的新型二氢喹啉吡唑基化合物
JP6622300B2 (ja) * 2014-10-31 2019-12-18 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft 新規なジヒドロキノリンピラゾリル化合物
CN106660998B (zh) * 2014-10-31 2019-10-25 豪夫迈·罗氏有限公司 吡唑基-3,4-二氢喹啉-2-酮醛固酮合酶抑制剂
WO2016089800A1 (en) * 2014-12-02 2016-06-09 Boehringer Ingelheim International Gmbh Aldosterone synthase inhibitors
KR20190016971A (ko) 2016-06-10 2019-02-19 니혼 메디피직스 가부시키가이샤 심질환의 비침습적 화상 진단제
JP2022530775A (ja) 2019-05-01 2022-07-01 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング (r)-(2-メチルオキシラン-2-イル)メチル 4-ブロモベンゼンスルホネート
EP4358959A1 (en) * 2021-06-24 2024-05-01 Cincor Pharma, Inc. Methods of using aldosterone synthase inhibitors
WO2023063851A1 (en) * 2021-10-13 2023-04-20 «Target Medicals» Limited Liability Company Inhibitors of human aldosterone synthase (cyp11b2)
WO2024049885A1 (en) 2022-09-02 2024-03-07 Apnimed, Inc. (Delaware) Methods and compositions for treating sleep apnea
WO2024061371A1 (zh) * 2022-09-23 2024-03-28 广州威诺森医药科技有限公司 一种骈环吡啶类甾体合成酶抑制剂及其制备方法和应用
WO2024109885A1 (zh) * 2022-11-23 2024-05-30 上海翰森生物医药科技有限公司 吡啶多环类化合物抑制剂、及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4792561A (en) * 1986-05-29 1988-12-20 Syntex (U.S.A.) Inc. Carbostyril derivatives as combined thromboxane synthetase and cyclic-AMP phosphodiesterase inhibitors
GB8709448D0 (en) 1987-04-21 1987-05-28 Pfizer Ltd Heterobicyclic quinoline derivatives
US5246944A (en) * 1991-08-13 1993-09-21 Merck & Co., Inc. Quinoline angiotensin ii antagonists incorporating a substituted benzyl element
WO2005065050A2 (ja) * 2003-12-25 2005-07-21 Asahi Kasei Pharma Corporation 2環化合物
AU2006326662B2 (en) 2005-12-09 2011-07-28 Amgen Inc. Quinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, and compositions, and uses thereof
DE102008022221A1 (de) 2008-05-06 2009-11-12 Universität des Saarlandes Inhibitoren der humanen Aldosteronsynthase CYP11B2

Also Published As

Publication number Publication date
PT2758388T (pt) 2018-04-17
DK2758388T3 (en) 2018-05-07
HRP20180592T1 (hr) 2018-05-18
BR112014006660A2 (pt) 2017-04-04
KR101723276B1 (ko) 2017-04-04
HUE038773T2 (hu) 2018-11-28
SG2014010599A (en) 2014-04-28
TWI576342B (zh) 2017-04-01
ZA201401577B (en) 2015-01-28
IL230874A0 (en) 2014-03-31
LT2758388T (lt) 2018-05-10
WO2013041591A1 (en) 2013-03-28
JP6012737B2 (ja) 2016-10-25
PE20181378A1 (es) 2018-09-05
US9353081B2 (en) 2016-05-31
MY186165A (en) 2021-06-30
NZ620652A (en) 2016-09-30
MX2014002624A (es) 2014-04-14
EA035108B1 (ru) 2020-04-28
KR20140076591A (ko) 2014-06-20
ES2666802T3 (es) 2018-05-07
SI2758388T1 (en) 2018-05-31
CO6870035A2 (es) 2014-02-20
UA115972C2 (uk) 2018-01-25
EA201490567A1 (ru) 2014-07-30
CR20140089A (es) 2014-03-21
IL230874A (en) 2016-07-31
CA2845170A1 (en) 2013-03-28
AU2012311582B2 (en) 2017-07-06
EP2758388B1 (en) 2018-02-21
CL2014000663A1 (es) 2014-10-03
US20130079365A1 (en) 2013-03-28
CA2845170C (en) 2019-08-13
EP2758388A1 (en) 2014-07-30
AU2012311582A1 (en) 2014-02-20
JP2014526539A (ja) 2014-10-06
AR087984A1 (es) 2014-04-30
MX366095B (es) 2019-06-27
NO2758388T3 (sr) 2018-07-21
TW201319054A (zh) 2013-05-16
CN103827101A (zh) 2014-05-28
PE20141042A1 (es) 2014-08-27
CN103827101B (zh) 2016-12-07
ECSP14013264A (es) 2014-04-30
BR112014006660B1 (pt) 2021-08-17
PL2758388T3 (pl) 2018-08-31

Similar Documents

Publication Publication Date Title
HK1206722A1 (en) New bicyclic derivatives
IL232570A0 (en) Bicyclic derivatives of dihydroisoquinoline-1-one
ZA201401577B (en) New bicyclic dihydroquinoline-2-one derivatives
SG10201601802YA (en) Dispiropyrrolidine derivatives
ZA201401884B (en) New dihydroquinoline-2-one derivatives
IL247638B (en) History of heteroaryl piperidine
IL231950B (en) Aryl-quinoline derivatives
EP2721029A4 (en) IMIDAZOPYRIDIN-2-ONE DERIVATIVES
EP2772485A4 (en) BICYCLIC CONNECTION
IL233001A0 (en) New iso-ergoline histories
SI2766342T1 (sl) Derivati fenil-gvanidina
ZA201308049B (en) 3-ureidoisoquinolin-8-yl derivatives
ZA201209319B (en) Cyclopropyl-indole derivatives